MAR 18, 2016 8:44 AM PDT

Infrared Sensor for the Detection of Alzheimer from Blood

WRITTEN BY: Xuan Pham
New patented diagnostic method for Alzheimer's detection

In the past several months, researchers have been focusing on easier point-of-care tests that offer early detection of diseases. One such test was recently proposed for Alzheimer’s disease, based on the idea of a portable biosensor that will diagnose disease progression by measuring beta-amyloid protein levels in the blood. However, such test has already been developed in Germany, and researchers recently reported 84 percent diagnostic precision from their first clinical trial.
 
The newly patented diagnostic test was developed by a research team at the Ruhr-University Bochum in Germany. Instead of just measuring levels of the beta-amyloid proteins, a signature of Alzheimer’s, the new test uses an infrared sensor that detects pathological misfolding of the protein. The presence of such misfolded proteins can occur more than 15 years before symptoms appear in the patients, and thus offer unprecedented early detection for the disease.
 
To assay beta-amyloid misfolding, the new test uses specific antibodies to attract protein biomarkers from cerebrospinal fluid samples or blood samples. The patent-pending infrared technology then scans the proteins for the presence and total distribution of secondary structures. Unlike other enzyme-linked immunosorbent assays (ELISA) that give the concentrations of abnormally folded proteins, the new test gives information on the distribution of the secondary structures, which could offer higher precision.
 
 "We do not merely select one single possible folding arrangement of the peptide; rather, we detect how all existing Amyloid beta secondary structures are distributed, in their healthy and in their pathological forms," said Klaus Gerwert, senior study author.
 
In a small clinical trial of 141 patients, the new test achieved a diagnostic precision of 84 percent in the blood and 90 per cent in cerebrospinal fluid. "What's unique about it is that this is the only robust label-free test with a single threshold," said Andreas Nabers, first study author.
 
Alzheimer’s disease is highly prevalent, accounting for over 7 million new cases every year. While there’s no cure yet, the detection and early diagnosis of the disease could influence patient care and outcome. According to the study authors, current diagnosis for the disease comes too late, as severe irreversible brain damages have already occurred in the time it takes for clinical symptoms to manifest. "If we wish to have a drug at our disposal that can significantly inhibit the progress of the disease, we need blood tests that detect Alzheimer's in its pre-dementia stages," said Gerwert. In catching Alzheimer early, researchers could have the rare opportunity to administer drugs to possibly prevent, or at the very least, delay its progression.
 

Additional source:  Ruhr-Universität Bochum press release
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 26, 2019
Cannabis Sciences
NOV 26, 2019
Cannabis Provides Relief from Headache and Migraine Pain
Innovative technology allowed researchers to conduct the first-ever study of cannabis use for the treatment of headache ...
DEC 23, 2019
Technology
DEC 23, 2019
Can Artifical Intelligence Detect Leukemia?
Artificial intelligence has always been a hot topic of discussion in the medical sciences with a whirlwind of applicatio ...
JAN 08, 2020
Clinical & Molecular DX
JAN 08, 2020
MicroRNA emerges as a biomarker for migraines
Intense, debilitating pain that can last for days. Nausea, numbness and sensitivity to light. For people who experience ...
MAR 25, 2020
Clinical & Molecular DX
MAR 25, 2020
A coronavirus testing kit with glow-in-the-dark Mango?
A group of Canadian researchers is responding to a desperate need for COVID-19 diagnostic kits with their fluorescent im ...
APR 04, 2020
Clinical & Molecular DX
APR 04, 2020
AI Finds New Predictive Markers of Covid-19 Severity
Researchers and healthcare organizations are putting their heads together to consider how technology could ease the ever ...
APR 21, 2020
Health & Medicine
APR 21, 2020
How to Read COVID-19 News (Without Going Crazy)
  It can feel like COVID-19 news is consuming the country, and taking all the toilet paper and N95-masks with it. N ...
Loading Comments...